Based on the Aurora Cannabis Inc stock forecast from 3 analysts, the average analyst target price for Aurora Cannabis Inc is CAD 9.38 over the next 12 months. Aurora Cannabis Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Aurora Cannabis Inc is Slightly Bearish, which is based on 4 positive signals and 5 negative signals. At the last closing, Aurora Cannabis Inc’s stock price was CAD 6.54. Aurora Cannabis Inc’s stock price has changed by +6.51% over the past week, +0.15% over the past month and -33.20% over the last year.
No recent analyst target price found for Aurora Cannabis Inc
No recent average analyst rating found for Aurora Cannabis Inc
Company Overview Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada. Read Less
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medica...Read More
Frequently Asked Questions About Aurora Cannabis Inc (ACB:CA) Stock
Based on ratings from 3 analysts Aurora Cannabis Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 3 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on ACB:CA's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for ACB:CA is CAD 9.38 over the next 12 months. The maximum analyst target price is CAD 10 while the minimum anlayst target price is CAD 8.5.
ACB:CA stock's Price/Earning ratio is 1,171.00.
Our analysis grades ACB:CA stock's Price / Earning ratio at F. This means that ACB:CA stock's Price/Earning ratio is above 93% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the TSX exchange.
Based on this ACB:CA may be a overvalued for its sector.
The last closing price of ACB:CA's stock was CAD 6.54.
The most recent market capitalization for ACB:CA is CAD 0.36B.
Based on targets from 3 analysts, the average taret price for ACB:CA is projected at CAD 9.38 over the next 12 months.
This means that ACB:CA's stock price may go up by +43.35% over the next 12 months.
We can't find any ETFs which contains Aurora Cannabis Inc's stock.
As per our most recent records Aurora Cannabis Inc has 1,073 Employees.
Aurora Cannabis Inc's registered address is 90B Street SW, Edmonton, AB, Canada, T6X 1V8.
You can get more information about it from Aurora Cannabis Inc's website at https://www.auroramj.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Aurora Cannabis Inc (ACB:CA) Stock
Based on ratings from 3 analysts Aurora Cannabis Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 3 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on ACB:CA's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for ACB:CA is CAD 9.38 over the next 12 months. The maximum analyst target price is CAD 10 while the minimum anlayst target price is CAD 8.5.
ACB:CA stock's Price/Earning ratio is 1,171.00.
Our analysis grades ACB:CA stock's Price / Earning ratio at F. This means that ACB:CA stock's Price/Earning ratio is above 93% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the TSX exchange.
Based on this ACB:CA may be a overvalued for its sector.
The last closing price of ACB:CA's stock was CAD 6.54.
The most recent market capitalization for ACB:CA is CAD 0.36B.
Based on targets from 3 analysts, the average taret price for ACB:CA is projected at CAD 9.38 over the next 12 months.
This means that ACB:CA's stock price may go up by +43.35% over the next 12 months.
We can't find any ETFs which contains Aurora Cannabis Inc's stock.
As per our most recent records Aurora Cannabis Inc has 1,073 Employees.
Aurora Cannabis Inc's registered address is 90B Street SW, Edmonton, AB, Canada, T6X 1V8.
You can get more information about it from Aurora Cannabis Inc's website at https://www.auroramj.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ACB:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
